These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16918891)

  • 1. Double-blind, randomized, placebo-controlled study to evaluate the effects of tegaserod on gastric motor, sensory and myoelectric function in healthy volunteers.
    Talley NJ; Camilleri M; Burton D; Thomforde G; Koch K; Rucker MJ; Peterson J; Zinsmeister AR; Earnest DL
    Aliment Pharmacol Ther; 2006 Sep; 24(5):859-67. PubMed ID: 16918891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind, randomized, placebo-controlled trial of itopride (100 and 200 mg three times daily) on gastric motor and sensory function in healthy volunteers.
    Choung RS; Talley NJ; Peterson J; Camilleri M; Burton D; Harmsen WS; Zinsmeister AR
    Neurogastroenterol Motil; 2007 Mar; 19(3):180-7. PubMed ID: 17300287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects.
    Degen L; Matzinger D; Merz M; Appel-Dingemanse S; Osborne S; Lüchinger S; Bertold R; Maecke H; Beglinger C
    Aliment Pharmacol Ther; 2001 Nov; 15(11):1745-51. PubMed ID: 11683688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oral CCK-1 agonist GI181771X on fasting and postprandial gastric functions in healthy volunteers.
    Castillo EJ; Delgado-Aros S; Camilleri M; Burton D; Stephens D; O'Connor-Semmes R; Walker A; Shachoy-Clark A; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2004 Aug; 287(2):G363-9. PubMed ID: 15246968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trial: effects of tegaserod on gastric motor and sensory function in patients with functional dyspepsia.
    Thumshirn M; Fruehauf H; Stutz B; Tougas G; Salter J; Fried M
    Aliment Pharmacol Ther; 2007 Nov; 26(10):1399-407. PubMed ID: 17892526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of tegaserod on proximal gastric tone and on the perception of gastric distension.
    Tack J; Vos R; Janssens J; Salter J; Jauffret S; Vandeplassche G
    Aliment Pharmacol Ther; 2003 Nov; 18(10):1031-7. PubMed ID: 14616170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of short-term, low-dose tricyclic and tetracyclic antidepressant treatment on satiation, postnutrient load gastrointestinal symptoms and gastric emptying: a double-blind, randomized, placebo-controlled trial.
    Choung RS; Cremonini F; Thapa P; Zinsmeister AR; Talley NJ
    Neurogastroenterol Motil; 2008 Mar; 20(3):220-7. PubMed ID: 18031471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of NK1 receptors on gastric motor functions and satiation in healthy humans: results from a controlled trial with the NK1 antagonist aprepitant.
    Jacob D; Busciglio I; Burton D; Halawi H; Oduyebo I; Rhoten D; Ryks M; Harmsen WS; Camilleri M
    Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G505-G510. PubMed ID: 28814387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of amitriptyline on gastric sensorimotor function and postprandial symptoms in healthy individuals: a randomized, double-blind, placebo-controlled trial.
    Bouras EP; Talley NJ; Camilleri M; Burton DD; Heckman MG; Crook JE; Richelson E
    Am J Gastroenterol; 2008 Aug; 103(8):2043-50. PubMed ID: 18803000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a somatostatin analogue on gastric motor and sensory functions in healthy humans.
    Foxx-Orenstein A; Camilleri M; Stephens D; Burton D
    Gut; 2003 Nov; 52(11):1555-61. PubMed ID: 14570722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a cannabinoid agonist on gastrointestinal transit and postprandial satiation in healthy human subjects: a randomized, placebo-controlled study.
    Esfandyari T; Camilleri M; Ferber I; Burton D; Baxter K; Zinsmeister AR
    Neurogastroenterol Motil; 2006 Sep; 18(9):831-8. PubMed ID: 16918762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers.
    Camilleri M; Bharucha AE; Ueno R; Burton D; Thomforde GM; Baxter K; McKinzie S; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G942-7. PubMed ID: 16603730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of tegaserod on gut transit in male and female subjects.
    Degen L; Petrig C; Studer D; Schroller S; Beglinger C
    Neurogastroenterol Motil; 2005 Dec; 17(6):821-6. PubMed ID: 16336497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tegaserod for dyspepsia and reflux symptoms in patients with chronic constipation: an exploratory open-label study.
    Zeng J; Zuo XL; Li YQ; Wei W; Lv GP
    Eur J Clin Pharmacol; 2007 Jun; 63(6):529-36. PubMed ID: 17468863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of GLP-1 on gastric volume, emptying, maximum volume ingested, and postprandial symptoms in humans.
    Delgado-Aros S; Kim DY; Burton DD; Thomforde GM; Stephens D; Brinkmann BH; Vella A; Camilleri M
    Am J Physiol Gastrointest Liver Physiol; 2002 Mar; 282(3):G424-31. PubMed ID: 11841992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of exenatide and erythromycin on postprandial symptoms and their relation to gastric functions.
    Yoon SB; Choi MG; Lim CH; Kim JS; Cho YK; Park JM; Lee IS; Kim SW; Choi KY; Chung IS
    Digestion; 2012; 85(3):211-8. PubMed ID: 22354133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of gastric emptying or accommodation with satiation, satiety, and postprandial symptoms in health.
    Halawi H; Camilleri M; Acosta A; Vazquez-Roque M; Oduyebo I; Burton D; Busciglio I; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G442-G447. PubMed ID: 28774870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome.
    Prather CM; Camilleri M; Zinsmeister AR; McKinzie S; Thomforde G
    Gastroenterology; 2000 Mar; 118(3):463-8. PubMed ID: 10702196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omeprazole delays gastric emptying in healthy volunteers: an effect prevented by tegaserod.
    Tougas G; Earnest DL; Chen Y; Vanderkoy C; Rojavin M
    Aliment Pharmacol Ther; 2005 Jul; 22(1):59-65. PubMed ID: 15963081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of ghrelin on the gastric accommodation reflex and on meal-induced satiety in man.
    Ang D; Nicolai H; Vos R; Mimidis K; Akyuz F; Kindt S; Vanden Berghe P; Sifrim D; Depoortere I; Peeters T; Tack J
    Neurogastroenterol Motil; 2009 May; 21(5):528-33, e8-9. PubMed ID: 19210631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.